SH229 tablets

· Nanjing Sanhome Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SH229 tablets, covering 2019-08-28 to 2019-08-28. Get the full timeline:

Most recent: Clinical Trial Update: SH229 Tablets Combined With Daclatasvir Dihydrochloride Tablets in Treatment Adult Patients With Chronic Hepatitis C [Phase 2, Phase 3]

See pricing